Page last updated: 2024-11-08

triperiden

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

triperiden: RN given refers to HCl [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID161077
SCHEMBL ID7438611
MeSH IDM0135122

Synonyms (25)

Synonym
33068-73-4
4-(diphenylmethyloxy)-1-methylpiperidine methylbromide quaternary salt
1-piperidinepropanol, alpha-phenyl-alpha-tricyclo(2.2.1.02,6)hept-3-yl-, hydrochloride (van)
norakin
piperidinium, 1,1-dimethyl-4-(diphenylmethoxy)-, bromide
p 260
triperiden
14617-17-5
unii-36wj53288e
36wj53288e ,
n-methylpiperidyl-(4)-benzhydrylaether methylbromid quaternister
n-methylpiperidyl-(4)-benzhydrylaether methylbromid quaternistert [german]
triperiden hydrochloride
1-piperidinepropanol, .alpha.-phenyl-.alpha.-tricyclo(2.2.1.02,6)hept-3-yl-, hydrochloride
triperiden hydrochloride [who-dd]
SCHEMBL7438611
Q4463153
1-phenyl-3-(piperidin-1-yl)-1-(tricyclo[2.2.1.0~2,6~]heptan-3-yl)propan-1-ol--hydrogen chloride (1/1)
DTXSID20932778
1-phenyl-3-piperidin-1-yl-1-(3-tricyclo[2.2.1.02,6]heptanyl)propan-1-ol;hydrochloride
F83856
MS-25355
HY-145391
CS-0372801
AKOS040756837
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (69.23)18.7374
1990's3 (23.08)18.2507
2000's1 (7.69)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.34

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.34 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.05 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.34)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (7.14%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (92.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]